CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy
European Journal of Immunology · 2026-11 · 56 (11)
DOI: 10.1002/eji.70324 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 16.11.2026. Verfasst von Giorgia Sartori und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Psoriasis, CD8-Positive T-Lymphocytes, Skin, Interleukin-23. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Tissue‐resident memory T cells (Trm) contribute to local immune responses and disease recurrence in psoriasis (PSO). This study investigated the phenotype and function of CD8 T cells with a Trm‐related phenotype in blood and skin samples from PSO patients and assessed their response to anti‐IL‐23 therapy. Circulating CLA+CD49a+ CD8 T cells were expanded in PSO compared with healthy controls and other inflammatory diseases. In skin, CD49a+ Trm subsets correlated with disease severity (psoriasis area severity index [PASI]). Functionally, CD49a expression was associated with IFNγ production, whereas CD103 identified IL17‐ and IL22‐producing cells. A triple‐positive CLA+CD103+CD49a+ subset was enriched in IL17+IL22+ cells and positively correlated with disease severity, suggesting a pathogenic role. Treatment with Tildrakizumab significantly reduced CLA+CD49a+ Trm cells, particularly the triple‐positive subset, along with IL17+IL22+ cells. In contrast, CLA‐CD49a+ cells persisted despite clinical remission, indicating a potential role in disease memory and relapse. Overall, the findings highlight the functional heterogeneity of CD8 Trm cells in PSO and identify distinct subsets associated with inflammation, therapeutic response, and disease persistence, supporting Trm cells as potential targets for more durable treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Surgery, Sapienza University of Rome, Rome, Italy.
- Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Sartori, G., Cammarata, I., Lopardo, R., Pacella, I., Cipriano, E., Ceccarelli, F., Marraffa, F., Conti, F., Rizzuto, G., Carlesimo, D., Dattola, A., Richetta, A. G., & Piconese, S. (2026). CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy. European Journal of Immunology, 56(11). https://doi.org/10.1002/eji.70324
Vancouver
Sartori G, Cammarata I, Lopardo R, Pacella I, Cipriano E, Ceccarelli F, et al. CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy. European Journal of Immunology. 2026;56(11). doi:10.1002/eji.70324
BibTeX
@article{Sartori2026,
author = {Sartori, Giorgia and Cammarata, Ilenia and Lopardo, Rossella and Pacella, Ilenia and Cipriano, Enrica and Ceccarelli, Fulvia and Marraffa, Federica and Conti, Fabrizio and Rizzuto, Giuseppe and Carlesimo, Davide and Dattola, Annunziata and Richetta, Antonio Giovanni and Piconese, Silvia},
title = {CLA+CD49a+ Cells Expand in Circulating CD8 and Skin Trm of Psoriasis Patients, Correlate With Severity, and Are Targeted by Anti‐IL23 Therapy},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {11},
doi = {10.1002/eji.70324}
}
EUVIMED